{"id":815528,"date":"2025-02-20T08:08:10","date_gmt":"2025-02-20T13:08:10","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/tectonic-therapeutic-to-participate-in-march-investor-conferences\/"},"modified":"2025-02-20T08:08:10","modified_gmt":"2025-02-20T13:08:10","slug":"tectonic-therapeutic-to-participate-in-march-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tectonic-therapeutic-to-participate-in-march-investor-conferences\/","title":{"rendered":"Tectonic Therapeutic to Participate in March Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">WATERTOWN, Mass., Feb.  20, 2025  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gZVOpIsc-HJ7C2SItRqTvaxHyzK1O0nZ5FcxQ3qnfrQIbq3EwZYAHwWSsxPVC1xlv7B9q_DGQyQMoDC_0PGd-DqA4GTbsxoJ1_rWpkyYrkQ=\" rel=\"nofollow\" target=\"_blank\">Tectonic Therapeutic, Inc.<\/a> (NASDAQ: TECX) (\u201cTectonic\u201d), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced that company management will participate in two upcoming investor conferences taking place in March 2025.<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td colspan=\"2\" style=\"max-width:50%;min-width:50%\">\n            <strong>TD Cowen 45<\/strong><br \/>\n            <sup><br \/>\n              <strong>th<\/strong><br \/>\n            <\/sup><br \/>\n            <strong> Annual Health Care Conference\u00a0<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:11%;width:11%;min-width:11%\">Date:<\/td>\n<td style=\"max-width:89%;width:89%;min-width:89%\">March 5, 2025<\/td>\n<\/tr>\n<tr>\n<td>Time:<\/td>\n<td>9:50 AM\u00a0EST<\/td>\n<\/tr>\n<tr>\n<td>Location:<\/td>\n<td>Boston, MA<\/td>\n<\/tr>\n<tr>\n<td>Format:<\/td>\n<td>Corporate Presentation<\/td>\n<\/tr>\n<tr>\n<td>Presenter:<\/td>\n<td>Alise Reicin, MD, President and Chief Executive Officer<\/td>\n<\/tr>\n<tr>\n<td>Webcast:<\/td>\n<td>\n            <a href=\"https:\/\/nam04.safelinks.protection.outlook.com\/?url=https%3A%2F%2Fwsw.com%2Fwebcast%2Fcowen177%2Ftecx%2F2031900&amp;data=05%7C02%7Cnkerrigan%40lifesciadvisors.com%7Ce227044e4bfc4b77424708dd3bcf139b%7C65ec683a30ce43d0a6ef2fd46d0f5e8a%7C0%7C0%7C638732482790990833%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=fraKUZdxJDQm9aUsFGkq11B9ZjMUls53h4An1s%2Bs6PU%3D&amp;reserved=0\" rel=\"nofollow\" target=\"_blank\"><br \/>\n              <strong>Link<\/strong><br \/>\n            <\/a>\u00a0<\/td>\n<\/tr>\n<\/table>\n<p>\n        \n      <\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td colspan=\"2\" style=\"max-width:50%;min-width:50%\">\n            <strong>Leerink Partners Global Healthcare Conference<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:11%;width:11%;min-width:11%\">Date:\u00a0<\/td>\n<td style=\"max-width:89%;width:89%;min-width:89%\">March 11, 2025<\/td>\n<\/tr>\n<tr>\n<td>Time:<\/td>\n<td>11:20 AM EDT<\/td>\n<\/tr>\n<tr>\n<td>Location:<\/td>\n<td>Miami, FL<\/td>\n<\/tr>\n<tr>\n<td>Format:<\/td>\n<td>Fireside Chat<\/td>\n<\/tr>\n<tr>\n<td>Presenters:<\/td>\n<td>Daniel Lochner, Chief Financial Officer, and Marc Schwabish, PhD, Chief Business Officer<\/td>\n<\/tr>\n<tr>\n<td>Webcast:<\/td>\n<td>\n            <a href=\"https:\/\/wsw.com\/webcast\/leerink38\/register.aspx?conf=leerink38&amp;page=tecx&amp;url=https:\/\/wsw.com\/webcast\/leerink38\/tecx\/2232100\" rel=\"nofollow\" target=\"_blank\"><br \/>\n              <strong>Link<\/strong><br \/>\n            <\/a>\u00a0<\/td>\n<\/tr>\n<tr>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<\/tr>\n<\/table>\n<p>Both live webcasts can also be accessed under \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gPkwr6YEPeGp-irtdI-VsxGs5GJdKYd5OVd5kIFU06-0xxOdOGgCYT5QoCYZ8EwTZCu1z5MXTalPZaiRuuKC43atL9nWa-6sZCThtejs3ZVpvdrfoCyLrNTlGtB2B0KgjHL8iesi_HAJMVcMekGGUJ90eMO8iQpDG03ekSNbHwk=\" rel=\"nofollow\" target=\"_blank\">Events &amp; Presentations<\/a>\u201d on the Investors section of the Tectonic website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EMfylbCjsmAeOLJ_7zCADXAHsqDLE45XiZVRSdZUnQHpft-w5hmF9oSS60lleG-TL2wkYKSoCzE_0Vq0PBYSD_tcGa2dt0EYo-_jjv-wxn8=\" rel=\"nofollow\" target=\"_blank\">www.tectonictx.com<\/a>. Once these conferences have concluded, a replay of the two webcasts will be available on the Company\u2019s website for approximately 90 days.<\/p>\n<p>The Tectonic management team will host one-on-one meetings during both conferences.\u00a0Interested investors should contact their\u00a0TD Cowen\u00a0and\/or Leerink representative to schedule meetings.<\/p>\n<p>\n        <strong>About Tectonic<\/strong><br \/>\n        <br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gZVOpIsc-HJ7C2SItRqTvbGHRuGg4O8j4xCUItEad5PUyyvtaNSfZZS2nYZHEtedLXV0QEWVaQAOZ9DhfwFW0w==\" rel=\"nofollow\" target=\"_blank\">Tectonic<\/a>\u00a0is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (\u201cGPCRs\u201d). Leveraging its proprietary technology platform called GEODe\u2122 (GPCRs Engineered for Optimal Discovery), Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery and harness the human body to modify the course of disease. Tectonic focuses on areas of significant unmet medical need, often where therapeutic options are poor or nonexistent, as these are areas where new medicines have the potential to improve patient quality of life. Tectonic is headquartered in\u00a0Watertown, Massachusetts. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EMfylbCjsmAeOLJ_7zCADSi5oo2Hiz9KTGcS9Ug2FVjwcoUKBxVdEC5_hnhu4GywkI1-EKsC5cPkEn-R0QkqcqHxdeuVa7AvpB1scrz3OEo=\" rel=\"nofollow\" target=\"_blank\">www.tectonictx.com\u00a0<\/a>and follow on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=TORSeiwU3HSwXDmExrxaCWz5lv7XuRGP_rIciBTxoWhji0cj1FA6RGpVpRyDjPPyqdphK1kI9lqNq3iOoZ4MY9IRbFaz-9iYLMGsaWKuumw=\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTM4NiM2NzU5NTY3IzIxMDAxNTc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NTNjODYzYjEtMGNmNy00ZDY4LWJiOWItNTc0NzI5NjhmZjFmLTExMTE3Mjg=\/tiny\/Tectonic-Therapeutic.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>Contacts:\r\n\r\nInvestors:\r\nDan Ferry\r\nLifeSci Advisors\r\n(617) 430-7576\r\ndaniel@lifesciadvisors.com\r\n\r\nMedia:\r\nKathryn Morris\r\nThe Yates Network\r\n(914) 204-6412\r\nkathryn@theyatesnetwork.com<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WATERTOWN, Mass., Feb. 20, 2025 (GLOBE NEWSWIRE) &#8212; Tectonic Therapeutic, Inc. (NASDAQ: TECX) (\u201cTectonic\u201d), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced that company management will participate in two upcoming investor conferences taking place in March 2025. TD Cowen 45 th Annual Health Care Conference\u00a0 Date: March 5, 2025 Time: 9:50 AM\u00a0EST Location: Boston, MA Format: Corporate Presentation Presenter: Alise Reicin, MD, President and Chief Executive Officer Webcast: Link \u00a0 Leerink Partners Global Healthcare Conference Date:\u00a0 March 11, 2025 Time: 11:20 AM EDT Location: Miami, FL Format: Fireside Chat Presenters: Daniel Lochner, Chief Financial Officer, and Marc Schwabish, PhD, Chief Business &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tectonic-therapeutic-to-participate-in-march-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Tectonic Therapeutic to Participate in March Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-815528","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Tectonic Therapeutic to Participate in March Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tectonic-therapeutic-to-participate-in-march-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tectonic Therapeutic to Participate in March Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WATERTOWN, Mass., Feb. 20, 2025 (GLOBE NEWSWIRE) &#8212; Tectonic Therapeutic, Inc. (NASDAQ: TECX) (\u201cTectonic\u201d), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced that company management will participate in two upcoming investor conferences taking place in March 2025. TD Cowen 45 th Annual Health Care Conference\u00a0 Date: March 5, 2025 Time: 9:50 AM\u00a0EST Location: Boston, MA Format: Corporate Presentation Presenter: Alise Reicin, MD, President and Chief Executive Officer Webcast: Link \u00a0 Leerink Partners Global Healthcare Conference Date:\u00a0 March 11, 2025 Time: 11:20 AM EDT Location: Miami, FL Format: Fireside Chat Presenters: Daniel Lochner, Chief Financial Officer, and Marc Schwabish, PhD, Chief Business &hellip; Continue reading &quot;Tectonic Therapeutic to Participate in March Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tectonic-therapeutic-to-participate-in-march-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-20T13:08:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTM4NiM2NzU5NTY3IzIxMDAxNTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tectonic-therapeutic-to-participate-in-march-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tectonic-therapeutic-to-participate-in-march-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Tectonic Therapeutic to Participate in March Investor Conferences\",\"datePublished\":\"2025-02-20T13:08:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tectonic-therapeutic-to-participate-in-march-investor-conferences\\\/\"},\"wordCount\":308,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tectonic-therapeutic-to-participate-in-march-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MTM4NiM2NzU5NTY3IzIxMDAxNTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tectonic-therapeutic-to-participate-in-march-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tectonic-therapeutic-to-participate-in-march-investor-conferences\\\/\",\"name\":\"Tectonic Therapeutic to Participate in March Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tectonic-therapeutic-to-participate-in-march-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tectonic-therapeutic-to-participate-in-march-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MTM4NiM2NzU5NTY3IzIxMDAxNTc=\",\"datePublished\":\"2025-02-20T13:08:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tectonic-therapeutic-to-participate-in-march-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tectonic-therapeutic-to-participate-in-march-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tectonic-therapeutic-to-participate-in-march-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MTM4NiM2NzU5NTY3IzIxMDAxNTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MTM4NiM2NzU5NTY3IzIxMDAxNTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tectonic-therapeutic-to-participate-in-march-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tectonic Therapeutic to Participate in March Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tectonic Therapeutic to Participate in March Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tectonic-therapeutic-to-participate-in-march-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Tectonic Therapeutic to Participate in March Investor Conferences - Market Newsdesk","og_description":"WATERTOWN, Mass., Feb. 20, 2025 (GLOBE NEWSWIRE) &#8212; Tectonic Therapeutic, Inc. (NASDAQ: TECX) (\u201cTectonic\u201d), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced that company management will participate in two upcoming investor conferences taking place in March 2025. TD Cowen 45 th Annual Health Care Conference\u00a0 Date: March 5, 2025 Time: 9:50 AM\u00a0EST Location: Boston, MA Format: Corporate Presentation Presenter: Alise Reicin, MD, President and Chief Executive Officer Webcast: Link \u00a0 Leerink Partners Global Healthcare Conference Date:\u00a0 March 11, 2025 Time: 11:20 AM EDT Location: Miami, FL Format: Fireside Chat Presenters: Daniel Lochner, Chief Financial Officer, and Marc Schwabish, PhD, Chief Business &hellip; Continue reading \"Tectonic Therapeutic to Participate in March Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tectonic-therapeutic-to-participate-in-march-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-20T13:08:10+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTM4NiM2NzU5NTY3IzIxMDAxNTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tectonic-therapeutic-to-participate-in-march-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tectonic-therapeutic-to-participate-in-march-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Tectonic Therapeutic to Participate in March Investor Conferences","datePublished":"2025-02-20T13:08:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tectonic-therapeutic-to-participate-in-march-investor-conferences\/"},"wordCount":308,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tectonic-therapeutic-to-participate-in-march-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTM4NiM2NzU5NTY3IzIxMDAxNTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tectonic-therapeutic-to-participate-in-march-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tectonic-therapeutic-to-participate-in-march-investor-conferences\/","name":"Tectonic Therapeutic to Participate in March Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tectonic-therapeutic-to-participate-in-march-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tectonic-therapeutic-to-participate-in-march-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTM4NiM2NzU5NTY3IzIxMDAxNTc=","datePublished":"2025-02-20T13:08:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tectonic-therapeutic-to-participate-in-march-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tectonic-therapeutic-to-participate-in-march-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tectonic-therapeutic-to-participate-in-march-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTM4NiM2NzU5NTY3IzIxMDAxNTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTM4NiM2NzU5NTY3IzIxMDAxNTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tectonic-therapeutic-to-participate-in-march-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Tectonic Therapeutic to Participate in March Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/815528","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=815528"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/815528\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=815528"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=815528"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=815528"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}